Beta 1 Beta blockers A - Propranolol,

Size: px
Start display at page:

Download "Beta 1 Beta blockers A - Propranolol,"

Transcription

1 Pharma Lecture 3 Beta blockers that we are most interested in are the ones that target Beta 1 receptors. Beta blockers A - Propranolol, it s a non-selective competitive antagonist of beta 1 and beta 2 receptors, it will bock the action of norepinephrine, it s used in many cardiac conditions. Effects: - A- Decrease Cardiac output B- Decreased Heart rate C- Decrease in contractile force D- Decrease in AV conduction E- Reduce sympathetic nervous system outflow F- Small vasoconstrictive effect (Increase in PVR) - Because these drugs work on beta adrenergic receptors on skeletal muscles that usually cause vasodilation when stimulated, but these drugs will inhibit them and vasoconstriction will therefore occur. G- Reduce renin release (Beta 1) - They are effective In patients with high renin activity, especially in younger patients who usually have hypertension due to high renin levels. H- Neutralize reflex tachycardia induced by Vasodilators- These group of drugs are beneficial as an adjuvant treatment for anti-hypertensive agents that cause tachycardia as their side effect. For example, some vasodilators cause reflex tachycardia and beta blockers such as propranolol are good drugs to neutralize this.

2 Side effects: - 1- Hypotension Generally all anti- hypertensive drugs cause hypotension 2- AV block, Bradycardia - They might predispose to arrythmias; therefore, we should be careful in giving these drugs to patients who have conduction problems or bradycardia. 3- Bronchial Constriction/spasm - They can act on smooth muscles of the bronchi and cause vasoconstriction; therefore, these drugs should be avoided in patients that suffer from Asthma. 4- Acute withdrawal syndrome (receptor super sensitivity) - For patients on beta blocker treatment for a long time we don t advise them to stop taking these drugs abruptly. This is because the body always tries to maintain homeostasis, so when you are constantly on beta blocker treatment, the body will be getting a lesser signal and will therefore upregulate the number of receptors or will increase their sensitivity. Now the patient will have the same amount of Norepinephrine as everyone else, but the number of receptors they may have will be greater than normal, all this norepinephrine will bind to these receptors and can predispose this patient to an ischemic attack. 5- Increase triglyceride levels and decrease HDL levels This will cause a problem in patients who have alterations in their lipid profiles. 6- Induce glucose intolerance We have to be careful in diabetic and obese patients. 7- May cause nightmares/depression They are lipid soluble and therefore can cross the blood brain barrier, the mechanism on how they may cause nightmares is unclear.

3 Contraindications:- 1- Bronchial Asthma Because they block Beta 2 receptors on skeletal muscles causing vasoconstriction 2- Peripheral vascular disease Because they cause an increase in PVR 3- Conduction problems/av block B- Atenolol It's a Beta 1 selective antagonist, less lipid soluble than other betaadrenergic antagonists, administered once daily. C- Metoprolol It's a Beta 1 selective antagonist, It s useful in Asthmatic patients. D- Nadolol It's Non-selective. Its advantage is that it is only administered once daily. Indications:- 1- Treatment of mild-moderate hypertension 2- Very useful for patients who are taking vasodilators, to prevent reflex tachycardia 3- Useful in controlling blood pressure in patients with underlying heart diseases.

4 ACE Inhibitors (Angiotensin converting enzyme inhibitors) These drugs work by acting on the Renal angiotensin system, mainly in the kidneys, and also in the blood vessels. *The doctor started talking about the history of these drugs, I didn t include it* Mechanism of Renin-angiotensin system: - Upon certain stimuli, such as low blood flow to the kidney, the kidney will start to secrete renin which will convert a peptide called angiotensinogen into angiotensin 1 and this will be worked upon by an enzyme called Angiotensin converting enzyme (ACE) in different parts of the body, to be converted into angiotensin 2. Angiotensin 2 has different functions in the body, one of the most important functions is that it regulates the blood pressure. Any decrease in blood pressure, will stimulate the renin release to produce angiotensin 2. Angiotensin 2 has two receptors, called AT1 & AT2. Now there will be changes when angiotensin binds to its receptors. 1- In the blood vessels we have AT1 receptors causing Vasoconstriction, cell growth & proliferation 2- In the kidneys we also have AT1 receptors causing aldosterone release, and when aldosterone is released it will cause sodium retention and will thus increase intravascular volume. 3- In the central nervous system it can cause central sympathetic activation. 4- AT2 receptor activation causes Vasodilation, restrains cell growth & proliferation, mediates Prostacyclin & NO release in the kidney, helps excrete sodium in the kidneys. In hypertension, we have elevated production of angiotensin 2. The effects of angiotensin 2 are seen more on AT1 receptors in this case.

5 ACE inhibitors block conversion of Angiotensin 1 to angiotensin 2. It also prevents the degradation of bradykinin to its inactive peptide. Bradykinin causes vasodilation which helps in the treatment of hypertension. These drugs are very useful in Diabetic patients because they slow the progression of renal disease in diabetes. Most ACE inhibitors end with the suffix Pril such as Enalapril, Ramipril, Lisinopril, Captopril. 1- Captopril One of the oldest ones, it s associated with multiple side effects because it contains a sulfhydryl moiety, and this causes allergic reactions. It also causes alteration in taste sensation. 2- Enalapril- Secreted mainly in kidney, so we should be careful in patients with renal insufficiency. 3- Ramipril works really fast, so peak concentration will be reached quickly. 4- Lisinopril Slowly absorbed, administered less frequently. Side effects: - 1- Hypotension in hypovolemic patients 2- Hyperkalemia as we said, when we block the action of aldosterone, more sodium will be excreted, and more potassium will be retained. 3- Angioedema- rapid swelling of throat, nose, mouth larynx or tongue. However, this is very rare 4- Cough- This is the most common side effect of ACE inhibitors, because bradykinin causes constriction in the bronchi and edema. 5- Skin rash 6- Taste alterations

6 These side effects are higher in African Americans. Many studies have shown that ACE inhibitors don t work very well in African Americans and Chinese people. Contraindications: - 1 Avoid use with Potassium sparring diuretics as they already cause hyperkalemia. So, use with Thiazides & Loop diuretics is fine. 2- Pregnancy They are contraindicated, because they will affect proliferation and cell growth, so if this is inhibited, it will affect the growth of the fetus. Angiotensin Receptor Blockers (ARB s) These drugs are Competitive antagonists of the AT1 receptor. They prevent binding of Angiotensin 2. Some people prefer these drugs over the ACE inhibitors because they have less side effects and the function of AT2 receptors, which is protective for the CVS, is preserved. However, in relation to lowering of blood pressure, there was no great difference between ACE inhibitors and ARB s. 1- Losartan They work mainly on Blood vessels and prevent binding of angiotensin 2 on the AT1 receptor and thus there will be more Vasodilation, and a decrease in TPR. They also will intervene with angiotensin ability to release aldosterone, so we will have more sodium excretion.

7 Side Effects: - 1- Angioedema This is not related to bradykinin, it is related to the vasodilatory effect of the blood vessels 2- Contraindicated in pregnancy - for the same reason as ACE inhibitors. 3- Dizziness ACEI or ARB? We can use both ACEI and ARB s in hypertensive patients with heart failure, renal disease, and diabetes. We use ACEI as the first choice unless the patient cannot handle the angioedema or cough, then we resort to using ARB s. Peripheral Alpha 1 adrenergic receptor blockers Prazosin is one of these drugs, it is a competitive inhibitor of the alpha 1 adrenergic receptors. Norepinephrine usually binds to the Alpha 1 receptor and causes Constriction of the vessels. So, Prazosin prevents the binding of norepinephrine and there will be less constriction and there will be dilation. They decrease PVR & BP. These drugs aren t used a lot as anti-hypertensives because they have side effects, and other drugs have shown better efficacy. Side effects: - 1- Postural dizziness 2- Headaches 3- Drowsiness

8 4- First dose phenomenon - when we give the patient this drug, he usually experiences a syncopal reaction orthostatic hypotension (upon standing). So, we advise the patient to take the drug at bed time so that he will not experience this side effect, the patient then develops tolerance to this reaction after the first dose. Other drugs from this family include Doxazosin, Terazosin. They have different pharmacokinetics. Doxazosin and Terazosin have a Longer half-life than Prazosin. And these two drugs are mainly used to treat benign prostate hypertrophy. People with this condition have a problem in emptying their bladders as a result of the hypertrophy of the prostate. So alpha 1 adrenergic receptors are on the neck of the bladder and their function is constriction, when they are inhibited, the patient can empty their bladder with much more ease. Recent recommendations on Alpha 1 Blockers Alpha 1 blockers are less effective than diuretics in preventing cardiovascular events, mainly heart failure. The National Institiute of health recommends not to use Alpha 1 blockers as the first drug of choice in hypertension (not effective in preventing heart failure) We usually give it as an additional drug with other drugs if we do not see an improvement in reduction of blood pressure. Adrenergic Neuron blocking agents/sympatholytics As we know, Sympathetic activation is involved in elevation of Blood pressure either by increasing the Cardiac output or increasing the Total peripheral resistance. These drugs work by decreasing the production/secretion of norepinephrine, we will have less of the effect of NE and therefore will have less of the sympathetic stimulation.

9 However, NE is necessary for many functions in the body. We will therefore have a lot of side effects, this is why they aren t used as a first line of treatment. 1- Guanethidine; it is a false Neurotransmitter. It will use the uptake mechanism of NE, it can take the place of NE and enter into the vesicle, and instead of NE being secreted from the vesicle, Guanethidine will be released, and it will have no effect on NE receptors. This drug is effective Orally. It does not cross the Blood brain barrier. Important: - We only use it in cases of Moderate-Severe cases of hypertension. We save this drug for cases of refractory hypertension, in which hypertension is not being resolved by any other drugs. 2- Reserpine; Prevents the uptake of Dopamine inside the vesicle, dopamine is a precursor of NE, so less uptake of dopamine means less production of NE, the NE stores will be depleted. It can also affect the uptake of Serotonin, however this is related to some side effects, such as depression. Sympathetic tone will be decreased, so we will have decreased TPR & CO. Side effects: - 1- Orthostatic hypotension 2- Depression 3- Nasal congestion 4- Bradycardia 5- Incompetence (guanethidine) 6- Diarrhea (guanethidine) 7- Salt and water retention

10 Drug interactions: - Amine pump is involved in the uptake of dopamine. There are drugs that can block this pump such as; Tricyclic antidepressants, monoamine oxidase inhibitors, ephedrine, amphetamines, phenothiazines. After chronic use of guanethidine, the above agents could cause hypertension due to development of receptor super sensitivity. It is RARELY INDICATED because of its adverse effects. It is often only used as a last resort in refractory hypertension.

Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs

Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs Blood Pressure Normal = sys

More information

Antihypertensive drugs SUMMARY Made by: Lama Shatat

Antihypertensive drugs SUMMARY Made by: Lama Shatat Antihypertensive drugs SUMMARY Made by: Lama Shatat Diuretic Thiazide diuretics The loop diuretics Potassium-sparing Diuretics *Hydrochlorothiazide *Chlorthalidone *Furosemide *Torsemide *Bumetanide Aldosterone

More information

7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension

7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension Prevalence of Hypertension Hypertension: Diagnosis and Management T. Villela, M.D. Program Director University of California, San Francisco-San Francisco General Hospital Family and Community Medicine

More information

HYPERTENSION: Sustained elevation of arterial blood pressure above normal o Systolic 140 mm Hg and/or o Diastolic 90 mm Hg

HYPERTENSION: Sustained elevation of arterial blood pressure above normal o Systolic 140 mm Hg and/or o Diastolic 90 mm Hg Lecture 39 Anti-Hypertensives B-Rod BLOOD PRESSURE: Systolic / Diastolic NORMAL: 120/80 Systolic = measure of pressure as heart is beating Diastolic = measure of pressure while heart is at rest between

More information

Antihypertensives. Antihypertensive Classes. RAAS Inhibitors. Renin-Angiotensin Cascade. Angiotensin Receptors. Approaches to Hypertension Treatment

Antihypertensives. Antihypertensive Classes. RAAS Inhibitors. Renin-Angiotensin Cascade. Angiotensin Receptors. Approaches to Hypertension Treatment Approaches to Hypertension Treatment Antihypertensives Inhibit Sympathetic impulses Inhibit contractility Inhibit heart rate Inhibit vasoconstriction Inhibit smooth muscle function Inhibit RAAS Inhibit

More information

Section 3, Lecture 2

Section 3, Lecture 2 59-291 Section 3, Lecture 2 Diuretics: -increase in Na + excretion (naturesis) Thiazide and Related diuretics -decreased PVR due to decreases muscle contraction -an economical and effective treatment -protect

More information

Antihypertensive Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Antihypertensive Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Antihypertensive Agents Part-2 Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Agents that block production or action of angiotensin Angiotensin-converting

More information

Prof dr Aleksandar Raskovic DIRECT VASODILATORS

Prof dr Aleksandar Raskovic DIRECT VASODILATORS Prof dr Aleksandar Raskovic DIRECT VASODILATORS Direct vasodilators Minoxidil (one of the most powerful peripheral arterial dilators) Opening of KATP channels, efflux of K, lose of Ca and smooth muscle

More information

Pharmacology of the Sympathetic Nervous System II

Pharmacology of the Sympathetic Nervous System II Pharmacology of the Sympathetic Nervous System II Edward JN Ishac, Ph.D. Professor Smith Building, Room 742 eishac@vcu.edu 828-2127 Department of Pharmacology and Toxicology Medical College of Virginia

More information

1. Antihypertensive agents 2. Vasodilators & treatment of angina 3. Drugs used in heart failure 4. Drugs used in arrhythmias

1. Antihypertensive agents 2. Vasodilators & treatment of angina 3. Drugs used in heart failure 4. Drugs used in arrhythmias 1. Antihypertensive agents 2. Vasodilators & treatment of angina 3. Drugs used in heart failure 4. Drugs used in arrhythmias Only need to know drugs discussed in class At the end of this section you should

More information

sympatholytics sympatholytics sympatholytics

sympatholytics sympatholytics sympatholytics sympatholytics sympatholytics sympatholytics CNS-ACTING SYMPATHOPLEGICS Sympathetic brain signals Doesn t affect baroreceptor reflex (no orthostatic hypotension) Methyldopa α-methylne crosses BBB (+) α-adrenoreceptors

More information

Introduction. Factors affecting blood pressure: 1-COP = HR X SV mainly affect SBP. 2-TPR = diameter of arterioles X viscosity of blood affect DBP

Introduction. Factors affecting blood pressure: 1-COP = HR X SV mainly affect SBP. 2-TPR = diameter of arterioles X viscosity of blood affect DBP Introduction Hypertension is a persistent elevation of blood pressure above 140 / 90 mmhg for more than three sitting. (0ptimal level

More information

Chapter 23. Media Directory. Cardiovascular Disease (CVD) Hypertension: Classified into Three Categories

Chapter 23. Media Directory. Cardiovascular Disease (CVD) Hypertension: Classified into Three Categories Chapter 23 Drugs for Hypertension Slide 37 Slide 41 Media Directory Nifedipine Animation Doxazosin Animation Upper Saddle River, New Jersey 07458 All rights reserved. Cardiovascular Disease (CVD) Includes

More information

Lab Period: Name: Physiology Chapter 14 Blood Flow and Blood Pressure, Plus Fun Review Study Guide

Lab Period: Name: Physiology Chapter 14 Blood Flow and Blood Pressure, Plus Fun Review Study Guide Lab Period: Name: Physiology Chapter 14 Blood Flow and Blood Pressure, Plus Fun Review Study Guide Main Idea: The function of the circulatory system is to maintain adequate blood flow to all tissues. Clinical

More information

HEART FAILURE PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

HEART FAILURE PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D HEART FAILURE PHARMACOLOGY University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D 1 LEARNING OBJECTIVES Understand the effects of heart failure in the body

More information

Towards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood:

Towards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood: Towards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood: Cardiac Output (CO) CO=SVxHR (stroke volume x heart rate) Cardiac output: The amount of blood

More information

M2 TEACHING UNDERSTANDING PHARMACOLOGY

M2 TEACHING UNDERSTANDING PHARMACOLOGY M2 TEACHING UNDERSTANDING PHARMACOLOGY USING CVS SYSTEM AS AN EXAMPLE NIGEL FONG 2 JAN 2014 TODAY S OBJECTIVE Pharmacology often seems like an endless list of mechanisms and side effects to memorize. To

More information

Antihypertensive Agents

Antihypertensive Agents Antihypertensive Agents Öner Süzer www.onersuzer.com osuzer@istanbul.edu.tr Last update: 13.11.2009 1 Süzer Farmakoloji 3. Baskı 2005 2 1 Süzer Farmakoloji 3. Baskı 2005 3 Süzer Farmakoloji 3. Baskı 2005

More information

Heart Failure (HF) Treatment

Heart Failure (HF) Treatment Heart Failure (HF) Treatment Heart Failure (HF) Complex, progressive disorder. The heart is unable to pump sufficient blood to meet the needs of the body. Its cardinal symptoms are dyspnea, fatigue, and

More information

HYPERTENSION IN CKD. LEENA ONGAJYOOTH, M.D., Dr.med RENAL UNIT SIRIRAJ HOSPITAL

HYPERTENSION IN CKD. LEENA ONGAJYOOTH, M.D., Dr.med RENAL UNIT SIRIRAJ HOSPITAL HYPERTENSION IN CKD LEENA ONGAJYOOTH, M.D., Dr.med RENAL UNIT SIRIRAJ HOSPITAL Stages in Progression of Chronic Kidney Disease and Therapeutic Strategies Complications Normal Increased risk Damage GFR

More information

DRUGS USED TO TREAT HYPERTENSION BY ALI ALALAWI

DRUGS USED TO TREAT HYPERTENSION BY ALI ALALAWI DRUGS USED TO TREAT HYPERTENSION BY ALI ALALAWI 3. Vasodilators Drugs which dilate blood vessels ( decrease peripheral vascular resistance) by acting on smooth muscle cells through non-autonomic mechanisms:

More information

Chapter 10 Worksheet Blood Pressure and Antithrombotic Agents

Chapter 10 Worksheet Blood Pressure and Antithrombotic Agents Complete the following. 1. A layer of cells lines each vessel in the vascular system. This layer is a passive barrier that keeps cells and proteins from going into tissues; it also contains substances

More information

Management of Hypertension

Management of Hypertension Clinical Practice Guidelines Management of Hypertension Definition and classification of blood pressure levels (mmhg) Category Systolic Diastolic Normal

More information

DRUG CLASSES BETA-ADRENOCEPTOR ANTAGONISTS (BETA-BLOCKERS)

DRUG CLASSES BETA-ADRENOCEPTOR ANTAGONISTS (BETA-BLOCKERS) DRUG CLASSES BETA-ADRENOCEPTOR ANTAGONISTS (BETA-BLOCKERS) Beta-blockers have been widely used in the management of angina, certain tachyarrhythmias and heart failure, as well as in hypertension. Examples

More information

Antihypertensives. Diagnostic category

Antihypertensives. Diagnostic category Measurement of blood pressure At first assessment, take both arms then choose the one with the higher reading. Beware of orthostatic hypotension. Measure BP in sitting position, and repeat after patient

More information

Hypertension (JNC-8)

Hypertension (JNC-8) Hypertension (JNC-8) Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 17, 2018, presented by Ezra Levy, Pharm.D.! The 8 th Joint

More information

Hypertension Update. Objectives 4/28/2015. Beverly J. Mathis, D.O. OOA May 2015

Hypertension Update. Objectives 4/28/2015. Beverly J. Mathis, D.O. OOA May 2015 Hypertension Update Beverly J. Mathis, D.O. OOA May 2015 Objectives Learn new recommendations for BP treatment goals Approach to hypertension in the office Use of hypertensive drugs, and how to tailor

More information

ANGIOTENSIN II RECEPTOR BLOCKERS: MORE THAN THE ALTERNATIVE PRESENTATION BY: PATRICK HO, USC PHARM D. CANDIDATE OF 2017 MENTOR: DR.

ANGIOTENSIN II RECEPTOR BLOCKERS: MORE THAN THE ALTERNATIVE PRESENTATION BY: PATRICK HO, USC PHARM D. CANDIDATE OF 2017 MENTOR: DR. ANGIOTENSIN II RECEPTOR BLOCKERS: MORE THAN THE ALTERNATIVE PRESENTATION BY: PATRICK HO, USC PHARM D. CANDIDATE OF 2017 MENTOR: DR. CRAIG STERN, PHARMD, MBA, RPH, FASCP, FASHP, FICA, FLMI, FAMCP RENIN-ANGIOTENSIN

More information

Cardiac Pathophysiology

Cardiac Pathophysiology Cardiac Pathophysiology Evaluation Components Medical history Physical examination Routine laboratory tests Optional tests Medical History Duration and classification of hypertension. Patient history of

More information

AUTONOMIC DRUGS: ADRENOCEPTOR AGONISTS AND SYMPATHOMIMETICS. Lecture 4

AUTONOMIC DRUGS: ADRENOCEPTOR AGONISTS AND SYMPATHOMIMETICS. Lecture 4 AUTONOMIC DRUGS: ADRENOCEPTOR AGONISTS AND SYMPATHOMIMETICS Lecture 4 Introduction (review) 5 key features of neurotransmitter function, which can be targets for pharmacotherapy Synthesis Storage Release

More information

LESSON ASSIGNMENT. After completing this lesson you will be able to:

LESSON ASSIGNMENT. After completing this lesson you will be able to: LESSON ASSIGNMENT SUBCOURSE MD0806 LESSON 7 Therapeutics III. Antihypertensive Agents. LESSON ASSIGNMENT Paragraphs 7-1--7-12. LESSON OBJECTIVES After completing this lesson you will be able to: 7-1. From

More information

- Dr Alia Shatnawi. 1 P a g e

- Dr Alia Shatnawi. 1 P a g e - 1 مها أبو عجمية - - - Dr Alia Shatnawi 1 P a g e A Skippable Intr0 Blood pressure normally decreases during the night. Absence of this phenomenon is called (nondipping) Wikipedia: Circadian rhythm....

More information

Antihypertensive drugs: I. Thiazide and other diuretics:

Antihypertensive drugs: I. Thiazide and other diuretics: Clinical assessment of hypertensive patient: You have to take history regarding the presence of other risk factors for CAb like diabetes mellitus, smoking, etc. Take history whether the patient takes medications

More information

Heart failure. Failure? blood supply insufficient for body needs. CHF = congestive heart failure. increased blood volume, interstitial fluid

Heart failure. Failure? blood supply insufficient for body needs. CHF = congestive heart failure. increased blood volume, interstitial fluid Failure? blood supply insufficient for body needs CHF = congestive heart failure increased blood volume, interstitial fluid Underlying causes/risk factors Ischemic heart disease (CAD) 70% hypertension

More information

Dr. Vishaal Bhat. anti-adrenergic drugs

Dr. Vishaal Bhat. anti-adrenergic drugs Dr. Vishaal Bhat anti-adrenergic drugs Divisions of human nervous system Human Nervous system Central Nervous System Peripheral Nervous System Autonomic Nervous System Nervous system Includes neurons and

More information

Treatment of Essential Hypertension

Treatment of Essential Hypertension 2016 edition by Mark A. Simmons, PhD Department of Pharmaceutical Sciences School of Pharmacy University of Maryland Eastern Shore Originally developed by Hugh J. Burford, PhD, FCP Department of Pharmacology

More information

(Second) #11. made by laith sorour corrected by. date 27/10

(Second) #11. made by laith sorour corrected by. date 27/10 (Second) #11 made by laith sorour corrected by date 27/10 Pre-lecture ( min 3.0) *last lecture we talked about parasympathetic nervous system about cholinergic drugs(agonists) & anti-cholinergic drugs(antagonists)

More information

Adrenergic agonists Sympathomimetic drugs. ANS Pharmacology Lecture 4 Dr. Hiwa K. Saaed College of Pharmacy/University of Sulaimani

Adrenergic agonists Sympathomimetic drugs. ANS Pharmacology Lecture 4 Dr. Hiwa K. Saaed College of Pharmacy/University of Sulaimani Adrenergic agonists Sympathomimetic drugs ANS Pharmacology Lecture 4 Dr. Hiwa K. Saaed College of Pharmacy/University of Sulaimani 2017-2018 Adrenergic agonists The adrenergic drugs affect receptors that

More information

Treatment of Essential Hypertension

Treatment of Essential Hypertension 2016 edition by Mark A. Simmons, PhD Department of Pharmaceutical Sciences School of Pharmacy University of Maryland Eastern Shore Originally developed by Hugh J. Burford, PhD, FCP Department of Pharmacology

More information

Top 200 Section 4. Cardiovascular Drugs

Top 200 Section 4. Cardiovascular Drugs Top 200 Section 4 Cardiovascular Drugs Objectives After finishing this presentation the audience should be able to: Describe conditions/disease states that would make a person a candidate for drug therapy.

More information

LESSON ASSIGNMENT Given the trade and/or generic name of an adrenergic blocking agent, classify that agent as either an alpha or beta blocker.

LESSON ASSIGNMENT Given the trade and/or generic name of an adrenergic blocking agent, classify that agent as either an alpha or beta blocker. LESSON ASSIGNMENT LESSON 8 Adrenergic Blocking Agents. TEXT ASSIGNMENT Paragraphs 8-1 through 8-5. LESSON OBJECTIVES 8-1. Given a group of statements, select the statement that best describes one of the

More information

Heart Failure. Subjective SOB (shortness of breath) Peripheral edema. Orthopnea (2-3 pillows) PND (paroxysmal nocturnal dyspnea)

Heart Failure. Subjective SOB (shortness of breath) Peripheral edema. Orthopnea (2-3 pillows) PND (paroxysmal nocturnal dyspnea) Pharmacology I. Definitions A. Heart Failure (HF) Heart Failure Ezra Levy, Pharm.D. HF Results when one or both ventricles are unable to pump sufficient blood to meet the body s needs There are 2 types

More information

Lujain Hamdan. Ayman Musleh & Yahya Salem. Mohammed khatatbeh

Lujain Hamdan. Ayman Musleh & Yahya Salem. Mohammed khatatbeh 12 Lujain Hamdan Ayman Musleh & Yahya Salem Mohammed khatatbeh the last lecture, we have studied the differences between the two divisions of the ANS: sympathetic and parasympathetic pathways which work

More information

Cardiovascular drugs

Cardiovascular drugs chapter 13 Cardiovascular drugs Cardiovascular drugs act on the heart or blood vessels to control the cardiovascular system. They are used to treat a variety of conditions from hypertension to chronic

More information

Systemic Pharmacology Lecture 7: Neuropharmacology

Systemic Pharmacology Lecture 7: Neuropharmacology Systemic Pharmacology Lecture 7: Neuropharmacology Drugs act on Sympathetic NS (adrenergic system) Adrenergic Drugs (Sympathomimetics), adrenergic agonists, or alpha- and beta-adrenergic agonists Antiadrenergic

More information

Autonomic Nervous System

Autonomic Nervous System Autonomic Nervous System Keri Muma Bio 6 Organization of the Nervous System Efferent Division Somatic Nervous System Voluntary control Effector = skeletal muscles Muscles must be excited by a motor neuron

More information

LXIV: DRUGS: 4. RAS BLOCKADE

LXIV: DRUGS: 4. RAS BLOCKADE LXIV: DRUGS: 4. RAS BLOCKADE ACE Inhibitors Components of RAS Actions of Angiotensin i II Indications for ACEIs Contraindications RAS blockade in hypertension RAS blockade in CAD RAS blockade in HF Limitations

More information

Hypertension Management - Summary

Hypertension Management - Summary Who should have blood pressure assessed? Hypertension Management - Summary All patients over the age of 40 years, every 1-3 years in order to determine their cardiovascular risk (ie. Framingham Risk Score)

More information

Heart Failure Pharmacotherapy An Update

Heart Failure Pharmacotherapy An Update Heart Failure Pharmacotherapy An Update Kenneth Mishler, PharmD, MBA Objectives Review the epidemiology of heart failure (HF) Review evidence based guidelines for the use of mediations used to treat HF

More information

Guideline-Directed Medical Therapy

Guideline-Directed Medical Therapy Guideline-Directed Medical Therapy Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation OPTIMAL THERAPY (As defined in

More information

Circulation. Blood Pressure and Antihypertensive Medications. Venous Return. Arterial flow. Regulation of Cardiac Output.

Circulation. Blood Pressure and Antihypertensive Medications. Venous Return. Arterial flow. Regulation of Cardiac Output. Circulation Blood Pressure and Antihypertensive Medications Two systems Pulmonary (low pressure) Systemic (high pressure) Aorta 120 mmhg Large arteries 110 mmhg Arterioles 40 mmhg Arteriolar capillaries

More information

ANTIHYPERTENSIVE DRUGS

ANTIHYPERTENSIVE DRUGS ANTIHYPERTENSIVE DRUGS Course: Integrated Therapeutics 1 Lecturer: Dr. E. Konorev Date: September 28, 2010 Materials on: Exam #3 Required reading: Katzung, Chapter 11 1 1 in 3 adults HYPERTENSION 64% of

More information

Hypertension CHAPTER-I CARDIOVASCULAR SYSTEM. Dr. K T NAIK Pharm.D Associate Professor Department of Pharm.D Krishna Teja Pharmacy College, Tirupati

Hypertension CHAPTER-I CARDIOVASCULAR SYSTEM. Dr. K T NAIK Pharm.D Associate Professor Department of Pharm.D Krishna Teja Pharmacy College, Tirupati CHAPTER-I CARDIOVASCULAR SYSTEM Hypertension SUB: PHARMACOTHERAPEUTICS-I CODE:T0820006 Dr. K T NAIK Pharm.D Associate Professor Department of Pharm.D Krishna Teja Pharmacy College, Tirupati Hypertension

More information

Antihypertensive Agents

Antihypertensive Agents Antihypertensive Agents Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 7, 08, presented by Ezra Levy, Pharm.D! Usual Dose,

More information

Antihypertensive Drugs. Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan November, 2014

Antihypertensive Drugs. Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan November, 2014 Antihypertensive Drugs Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan November, 2014 Antihypertensive Drugs What is Hypertension: A common, incurable, persistent, but usually

More information

Difficult to Treat Hypertension

Difficult to Treat Hypertension Difficult to Treat Hypertension According to Goldilocks JNC 8 Blood Pressure Goals (2014) BP Goal 60 years old and greater*- systolic < 150 and diastolic < 90. (Grade A)** BP Goal 18-59 years old* diastolic

More information

Pharmacology - Problem Drill 11: Vasoactive Agents

Pharmacology - Problem Drill 11: Vasoactive Agents Pharmacology - Problem Drill 11: Vasoactive Agents Question No. 1 of 10 1. Vascular smooth muscle contraction is triggered by a rise in. Question #01 (A) Luminal calcium (B) Extracellular calcium (C) Intracellular

More information

STANDARD treatment algorithm mmHg

STANDARD treatment algorithm mmHg STANDARD treatment algorithm 130-140mmHg (i) At BASELINE, If AVERAGE SBP 1 > 140mmHg If on no antihypertensive drugs: Start 1 drug: If >55 years old / Afro-Caribbean: Calcium channel blocker (CCB) 2 If

More information

Heart Failure. Acute. Plasma [NE] (pg/ml) 24 Hours. Chronic

Heart Failure. Acute. Plasma [NE] (pg/ml) 24 Hours. Chronic Heart Failure Heart failure is the inability of the heart to deliver sufficient blood to the tissues to ensure adequate oxygen supply. Clinically it is characterized by signs of volume overload or symptoms

More information

Categories of HTN. Overview of Hypertension. Types of Hypertension

Categories of HTN. Overview of Hypertension. Types of Hypertension Categories of HTN Overview of Hypertension Normal SBP 100 Quick review of the Basics: What is

More information

Antihypertensive Agents

Antihypertensive Agents 1. Blood Pressure Regulation Antihypertensive Agents - 2007 Edward JN Ishac. Ph.D. Associate Professor, Dept. Pharmacology & Toxicology Office: Smith 742; Tel: 828 2127 eishac@hsc.vcu.edu Frank's formula,

More information

Angina pectoris due to coronary atherosclerosis : Atenolol is indicated for the long term management of patients with angina pectoris.

Angina pectoris due to coronary atherosclerosis : Atenolol is indicated for the long term management of patients with angina pectoris. Lonet Tablet Description Lonet contains Atenolol, a synthetic β1 selective (cardioselective) adrenoreceptor blocking agent without membrane stabilising or intrinsic sympathomimetic (partial agonist) activity.

More information

Hypertension Management: A Moving Target

Hypertension Management: A Moving Target 9:45 :30am Hypertension Management: A Moving Target SPEAKER Karol Watson, MD, PhD, FACC Presenter Disclosure Information The following relationships exist related to this presentation: Karol E. Watson,

More information

1. Despite the plethora of new ACE-inhibitors they offer little advantage over the earlier products captopril and enalapril.

1. Despite the plethora of new ACE-inhibitors they offer little advantage over the earlier products captopril and enalapril. SUMMARY 1. Despite the plethora of new ACE-inhibitors they offer little advantage over the earlier products captopril and enalapril. 2. While diuretics and beta-blockers remain first-line antihypertensive

More information

sympathetic nerve impulses endogenous catecholamines beta adrenergic drugs

sympathetic nerve impulses endogenous catecholamines beta adrenergic drugs Beta adrenergic blockers } These drugs will bind and prevent beta-receptors from responding to: sympathetic nerve impulses endogenous catecholamines beta adrenergic drugs the use of beta antagonists is

More information

1/4/18. Heart Failure Guideline Review and Update. Disclosure. Pharmacist Objectives. Pharmacy Technician Objectives. What is Heart Failure?

1/4/18. Heart Failure Guideline Review and Update. Disclosure. Pharmacist Objectives. Pharmacy Technician Objectives. What is Heart Failure? Disclosure Heart Failure Guideline Review and Update I have had no financial relationship over the past 12 months with any commercial sponsor with a vested interest in this presentation. Natalie Beiter,

More information

ANTIHYPERTENSIVE AGENTS AND VASODILATORS. Lecture 5

ANTIHYPERTENSIVE AGENTS AND VASODILATORS. Lecture 5 ANTIHYPERTENSIVE AGENTS AND VASODILATORS Lecture 5 Hypertension Blood pressure BP = CO x PVR n Interaction between autonomic nervous system, cardiovascular system and renal system Normal: 110/70 Prehypertension

More information

Combination of renin-angiotensinaldosterone. how to choose?

Combination of renin-angiotensinaldosterone. how to choose? Combination of renin-angiotensinaldosterone system inhibitors how to choose? Karl Swedberg Professor of Medicine Sahlgrenska Academy University of Gothenburg karl.swedberg@gu.se Disclosures Research grants

More information

What is Hypertension?

What is Hypertension? What is Hypertension? What is hypertension? Hypertension is also known as high blood pressure. Our blood needs to be under pressure to make it move around the body, but when it is too high this causes

More information

Antihypertensive Drugs. Munir Gharaibeh, MD, PhD, MHPE School of Medicine, The University of Jordan October, 2017

Antihypertensive Drugs. Munir Gharaibeh, MD, PhD, MHPE School of Medicine, The University of Jordan October, 2017 Antihypertensive Drugs Munir Gharaibeh, MD, PhD, MHPE School of Medicine, The University of Jordan October, 2017 Antihypertensive Drugs What is Hypertension? A common, incurable, persistent, but usually

More information

Antihypertensives. Alia Shatanawi Associate Professor Department of Pharmacology School of Medicine University of Jordan

Antihypertensives. Alia Shatanawi Associate Professor Department of Pharmacology School of Medicine University of Jordan Antihypertensives Alia Shatanawi Associate Professor Department of Pharmacology School of Medicine University of Jordan shatanawi79@gmail.com Blood Pressure Blood pressure is the force that circulating

More information

Difficult to Control HTN: It is not all the same. Structured approach to evaluation and treatment

Difficult to Control HTN: It is not all the same. Structured approach to evaluation and treatment Difficult to Control HTN: It is not all the same. Structured approach to evaluation and treatment Dmitri Vasin M.D. Nephrologist and ASH certified clinical hypertension specialist Bremerton, WA, USA Johnson

More information

These drugs produce effects similar to the sympathetic nervous system

These drugs produce effects similar to the sympathetic nervous system Terms adrenergic Drugs mydriasis sympathetic nervous system adrenergic drugs adrenergic mechanism of action positive inotropic effect positive chronotropic effect positive dromotropic effect adrenergic

More information

Heart Failure. Dr. Alia Shatanawi

Heart Failure. Dr. Alia Shatanawi Heart Failure Dr. Alia Shatanawi Left systolic dysfunction secondary to coronary artery disease is the most common cause, account to 70% of all cases. Heart Failure Heart is unable to pump sufficient blood

More information

β adrenergic blockade, a renal perspective Prof S O McLigeyo

β adrenergic blockade, a renal perspective Prof S O McLigeyo β adrenergic blockade, a renal perspective Prof S O McLigeyo Carvedilol Third generation β blocker (both β 1 and β 2 ) Possesses α 1 adrenergic blocking properties. β: α blocking ratio 7:1 to 3:1 Antioxidant

More information

By Prof. Khaled El-Rabat

By Prof. Khaled El-Rabat What is The Optimum? By Prof. Khaled El-Rabat Professor of Cardiology - Benha Faculty of Medicine HT. Introduction Despite major worldwide efforts over recent decades directed at diagnosing and treating

More information

Composition Each ml of Ventol solution for inhalation contains 5 mg Salbutamol (as sulphate).

Composition Each ml of Ventol solution for inhalation contains 5 mg Salbutamol (as sulphate). VENTOL Composition Each ml of Ventol solution for inhalation contains 5 mg Salbutamol (as sulphate). Respiratory Solution Action Salbutamol is a short-acting, relatively selective beta2-adrenoceptor agonist.

More information

Blood Pressure. a change in any of these could cause a corresponding change in blood pressure

Blood Pressure. a change in any of these could cause a corresponding change in blood pressure Blood Pressure measured as mmhg Main factors affecting blood pressure: 1. cardiac output 2. peripheral resistance 3. blood volume a change in any of these could cause a corresponding change in blood pressure

More information

Definition of Congestive Heart Failure

Definition of Congestive Heart Failure Heart Failure Definition of Congestive Heart Failure A clinical syndrome of signs & symptoms resulting from the heart s inability to supply adequate tissue perfusion. CHF Epidemiology Affects 4.7 million

More information

Hypertension Update Warwick Jaffe Interventional Cardiologist Ascot Hospital

Hypertension Update Warwick Jaffe Interventional Cardiologist Ascot Hospital Hypertension Update 2008 Warwick Jaffe Interventional Cardiologist Ascot Hospital Definition of Hypertension Continuous variable At some point the risk becomes high enough to justify treatment Treatment

More information

University of Al Qadisiyah College of Pharmacy Dr. Bassim I Mohammad, MBChB, MSc, Ph.D

University of Al Qadisiyah College of Pharmacy Dr. Bassim I Mohammad, MBChB, MSc, Ph.D University of Al Qadisiyah College of Pharmacy Dr. Bassim I Mohammad, MBChB, MSc, Ph.D Cardiovascular Pharmacology 1. Antihypertensives 2. Antianginal 3. Drugs for HF 4. Antiarrythemics 5. Drugs for Hyperlipoproteniemia

More information

The adrenergic drugs affect receptors that are stimulated by norepinephrine or epinephrine. Some adrenergic drugs act directly on the adrenergic

The adrenergic drugs affect receptors that are stimulated by norepinephrine or epinephrine. Some adrenergic drugs act directly on the adrenergic Adrenergic drugs The adrenergic drugs affect receptors that are stimulated by norepinephrine or epinephrine. Some adrenergic drugs act directly on the adrenergic receptor (adrenoceptor) by activating it

More information

Pheochromocytoma: Effects of Catecholamines

Pheochromocytoma: Effects of Catecholamines 36 PHYSIOLOGY CASES AND PROBLEMS Case 8 Pheochromocytoma: Effects of Catecholamines Helen Ames is a 51-year-old homemaker who experienced what she thought were severe menopausal symptoms. These awful "attacks"

More information

Medical Translation: Welcome to our webinar

Medical Translation: Welcome to our webinar r Welcome to our webinar Medical Translation: The Pharmacodynamics and Physiological Effects of Drug Classes Commonly Studied during Clinical Trials with Carmen Cross 13 February 2014 www.ecpdwebinars.co.uk

More information

Dr Narender Goel MD (Internal Medicine and Nephrology) Financial Disclosure: None, Conflict of Interest: None

Dr Narender Goel MD (Internal Medicine and Nephrology) Financial Disclosure: None, Conflict of Interest: None Dr Narender Goel MD (Internal Medicine and Nephrology) drnarendergoel@gmail.com Financial Disclosure: None, Conflict of Interest: None 12 th December 2013, New York Visit us at: http://kidneyscience.info/

More information

CASE 13. What neural and humoral pathways regulate arterial pressure? What are two effects of angiotensin II?

CASE 13. What neural and humoral pathways regulate arterial pressure? What are two effects of angiotensin II? CASE 13 A 57-year-old man with long-standing diabetes mellitus and newly diagnosed hypertension presents to his primary care physician for follow-up. The patient has been trying to alter his dietary habits

More information

a)-catecholamines // these are compounds which have the catechol nucleus as adrenaline, noradrenaline, isoprenaline, dopamine, dobutamine

a)-catecholamines // these are compounds which have the catechol nucleus as adrenaline, noradrenaline, isoprenaline, dopamine, dobutamine 1 Adrenergic or sympathetic agonist: Are classified according to: I)- according to the chemical structure a)-catecholamines // these are compounds which have the catechol nucleus as adrenaline, noradrenaline,

More information

Neprilysin Inhibitor (Entresto ) Prior Authorization and Quantity Limit Program Summary

Neprilysin Inhibitor (Entresto ) Prior Authorization and Quantity Limit Program Summary Neprilysin Inhibitor (Entresto ) Prior Authorization and Quantity Limit Program Summary FDA APPROVED INDICATIONS DOSAGE 1 Indication Entresto Reduce the risk of cardiovascular (sacubitril/valsartan) death

More information

Congestive Heart Failure

Congestive Heart Failure Congestive Heart Failure (CHF) Congestive Heart Failure - 2007 Edward JN Ishac. Ph.D. Associate Professor, Dept. Pharmacology & Toxicology Office: Smith 742; Tel: 828 2127 eishac@vcu.edu Heart failure:

More information

Metabolic Consequences of Anti Hypertensives: Is It Clinically Important?

Metabolic Consequences of Anti Hypertensives: Is It Clinically Important? Metabolic Consequences of Anti Hypertensives: Is It Clinically Important?,FACA,FICA,MASH,FVBWG,MISCP CONSULTANT OF CARDIOLOGY DIRECTOR OF PORT-FOUAD HOSPITAL CCU Consideration of antihypertensive agents

More information

Summary/Key Points Introduction

Summary/Key Points Introduction Summary/Key Points Introduction Scope of Heart Failure (HF) o 6.5 million Americans 20 years of age have HF o 960,000 new cases of HF diagnosed annually o 5-year survival rate for HF is ~50% Classification

More information

Autonomic Pharmacology

Autonomic Pharmacology Autonomic Pharmacology ADRENERGIC RECEPTOR BLOCKERS Adrenergic-receptor antagonists block the effects of sympathetic stimulation and adrenergic agonists mediated through - and -receptors. Adrenergic receptor

More information

COMPLEX HYPERTENSION. Anita Ralstin, FNP-BC Next Step Health Consultant, LLC

COMPLEX HYPERTENSION. Anita Ralstin, FNP-BC Next Step Health Consultant, LLC COMPLEX HYPERTENSION Anita Ralstin, FNP-BC Next Step Health Consultant, LLC Incidence Of Hypertension About 70 million American adults have high blood pressure. About 33% of the population Only 52% have

More information

Eplerenon Medical Valley + Eplerenon Stada

Eplerenon Medical Valley + Eplerenon Stada VI.2 Elements for a Public Summary VI.2.1 Overview of disease epidemiology Heart failure is a complex syndrome, clinically characterized by signs and symptoms secondary to abnormal cardiac function. It

More information

BIPN100 F15 Human Physiol I (Kristan) Lecture 14 Cardiovascular control mechanisms p. 1

BIPN100 F15 Human Physiol I (Kristan) Lecture 14 Cardiovascular control mechanisms p. 1 BIPN100 F15 Human Physiol I (Kristan) Lecture 14 Cardiovascular control mechanisms p. 1 Terms you should understand: hemorrhage, intrinsic and extrinsic mechanisms, anoxia, myocardial contractility, residual

More information

HYPERTENSION IN EMERGENCY MEDICINE Michael Jay Bresler, M.D., FACEP

HYPERTENSION IN EMERGENCY MEDICINE Michael Jay Bresler, M.D., FACEP HYPERTENSION IN EMERGENCY MEDICINE Michael Jay Bresler, M.D., FACEP What is normal blood pressure? Prehypertension 130-139/80-90 Compared with normal BP Double the risk for developing hypertension. Lifestyle

More information

Estimated 5.7 million Americans with HF. 915, 000 new HF cases annually, HF incidence approaches

Estimated 5.7 million Americans with HF. 915, 000 new HF cases annually, HF incidence approaches Heart Failure: Management of a Chronic Disease Jenny Bauerly RN, CHFN, APRN-BC Heart Failure (HF) Definition A complex clinical syndrome that can result from any structural or functional cardiac disorder

More information

8/20/2018. Objectives. What is hypertension? cont. What is hypertension? Epidemiology cont. Epidemiology

8/20/2018. Objectives. What is hypertension? cont. What is hypertension? Epidemiology cont. Epidemiology Objectives Hypertension (high blood pressure): Clinical Pearls for the Pharmacy Technician Tanya Schmidt PharmD, RPh Director of Central Operations at Thrifty White Pharmacy North Dakota Board of Pharmacy

More information

Anti-hypertensive agents

Anti-hypertensive agents Anti-hypertensive agents Dr. Pran Kishore Deb Assistant Professor, Pharmaceutical Medicinal Chemistry Faculty of Pharmacy, Philadelphia University-Jordan Email: pdeb@philadelphia.edu.jo Anti-hypertensive

More information

New classification of HT Systolic Diastolic Normal <120 <80 Prehypertension Stage1HT Stage 2 HT >160 or >100

New classification of HT Systolic Diastolic Normal <120 <80 Prehypertension Stage1HT Stage 2 HT >160 or >100 Hypertension 1 Definition Hypertension can be defined as a condition where blood pressure is elevated to an extent that clinical benefit is obtained from blood pressure lowering. it is an important risk

More information